Board Advisor – Pharma & API Strategy

About the Company

A well-established API manufacturer with GMP-compliant plants in India. The company operates at a stable large revenue scale and is predominantly export-oriented, with a strong presence in international regulated markets. The Family Office is a part of a large conglomerate and holds a significant stake in the pharma entity and is seeking to add a Board-level advisor who can provide independent, high-quality strategic guidance to accelerate this trajectory.

Roles and Responsibilities

• The Board Advisor will serve as the Family Office’s strategic eyes and ears on the pharma portfolio — offering a seasoned, independent perspective to the Managing Partner and, where relevant, to the Board and senior management.
• Strategic Product & Pipeline Advisory
• Evaluate existing and prospective product pipeline against near and long-term growth objectives
• Advise on the right molecules to target and the most promising global markets to pursue
• Assess whether the current pipeline is calibrated to meet the company’s next phase of growth, and recommend course corrections where needed
• Provide a view on new product strategy, including identification of high-value APIs with strong regulatory and commercial prospects
• Value Chain & Business Model Evolution
• Guide the company’s thinking on the natural progression for an API business
• Advise on the strategic, operational, and financial trade-offs of each pathway, with a clear articulation of risks and mitigation strategies
• Help management and the Board understand what it takes to transition, and whether the company is ready to make that move
• Regulatory & Market Intelligence
• Leverage experience with USFDA, EMA, and other regulated market approvals to advise on sustaining and expanding the company’s regulatory standing
• Provide intelligence on shifting global regulatory landscapes, therapeutic area trends, and competitive API markets
• Identify risks in existing markets and opportunities in new geographies or therapeutic segments
• Revenue Growth & Shareholder Value
• Advise on realistic pathways to ramp up revenue from the existing base, through pricing, customer mix, volume expansion, and new partnerships
• Offer a shareholder-aligned perspective on capital allocation, partnership structures, and strategic investments
• Provide scenario analysis and pros/cons frameworks to support high-stakes strategic decisions

Skills and qualifications

• 25+ years of experience in the pharmaceutical industry, with deep and direct expertise in API manufacturing and strategy
• Proven track record in building or scaling API businesses across regulated global markets (US, EU, Japan, or equivalent)
• Hands-on experience with USFDA inspections, GMP compliance, and regulated market drug approvals
• Broad exposure across the pharma value chain: API → R&D → CDMO → FDF → Drug Development is highly desirable
• Experience in specialty APIs, or complex molecules is a strong advantage
• Senior executives, former CEOs, plant heads, regulatory affairs leaders, or BD heads from major pharma or API companies are encouraged to apply
• Industry veterans who have recently transitioned out of full-time executive roles and are open to selective advisory or Board-level engagements
• Professionals with a global perspective on API markets and an established network across pharma companies, CDMOs, and regulatory bodies
• Individuals who bring a holistic view of the pharma lifecycle — from molecule selection and manufacturing to commercialization and market access

What's On Offer

Shape the next chapter of a high-performing Indian API company — a selective, Board-level engagement designed around the experience and pace of a seasoned industry leader.